Bumrungrad Hospital PCL (BUGDF)
7.914
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Bumrungrad Hospital Revenue (Quarterly): 171.58M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 171.58M |
| March 31, 2024 | 183.12M |
| December 31, 2023 | 182.14M |
| September 30, 2023 | 191.02M |
| June 30, 2023 | 175.54M |
| March 31, 2023 | 179.26M |
| December 31, 2022 | 164.74M |
| September 30, 2022 | 156.30M |
| June 30, 2022 | 143.14M |
| March 31, 2022 | 124.55M |
| December 31, 2021 | 116.57M |
| September 30, 2021 | 88.41M |
| June 30, 2021 | 95.49M |
| March 31, 2021 | 87.54M |
| December 31, 2020 | 95.67M |
| September 30, 2020 | 92.42M |
| June 30, 2020 | 76.09M |
| March 31, 2020 | 131.43M |
| December 31, 2019 | 157.47M |
| September 30, 2019 | 154.33M |
| June 30, 2019 | 135.85M |
| March 31, 2019 | 147.35M |
| December 31, 2018 | 143.85M |
| September 30, 2018 | 142.79M |
| June 30, 2018 | 133.23M |
| Date | Value |
|---|---|
| March 31, 2018 | 146.69M |
| December 31, 2017 | 138.02M |
| September 30, 2017 | 143.35M |
| June 30, 2017 | 127.21M |
| March 31, 2017 | 124.92M |
| December 31, 2016 | 122.16M |
| September 30, 2016 | 131.79M |
| June 30, 2016 | 123.27M |
| March 31, 2016 | 129.53M |
| December 31, 2015 | 127.06M |
| September 30, 2015 | 122.86M |
| June 30, 2015 | 131.93M |
| March 31, 2015 | 134.02M |
| December 31, 2014 | 127.46M |
| September 30, 2014 | 126.48M |
| June 30, 2014 | 116.21M |
| March 31, 2014 | 110.08M |
| December 31, 2013 | 115.10M |
| September 30, 2013 | 116.54M |
| June 30, 2013 | 117.26M |
| March 31, 2013 | 116.56M |
| December 31, 2012 | 106.13M |
| September 30, 2012 | 105.47M |
| June 30, 2012 | 102.12M |
| March 31, 2012 | 102.56M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
76.09M
Minimum
Jun 2020
191.02M
Maximum
Sep 2023
137.50M
Average
143.14M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Bangkok Dusit Medical Services PCL | 699.75M |
| NewGenIvf Group Ltd | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.05M |
| IGC Pharma Inc | 0.272M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.59M |
| Total Expenses (Quarterly) | 108.54M |
| EPS Diluted (Quarterly) | 0.0607 |
| Enterprise Value | 5.998B |
| Gross Profit Margin (Quarterly) | 52.27% |
| Profit Margin (Quarterly) | 30.65% |
| Earnings Yield | 3.09% |
| Operating Earnings Yield | 3.72% |
| Normalized Earnings Yield | 3.076 |